Tokyo, Japan

Hirotsune Itahana

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Astellas Pharma Gmbh, Yamanouchi Pharmaceutical Company Ltd.. Active years: 1998-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hirotsune Itahana. Retrieved from https://idiyas.com/inventor/hirotsune-itahana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 25.0


Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Ibaraki, JP (1998 - 2003)
  • Tsukuba, JP (2007)
  • Tokyo, JP (2011)

Company Filing History:


Years Active: 1998-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hirotsune Itahana: An Innovator in Pharmaceutical Chemistry

Introduction

Hirotsune Itahana is a distinguished inventor based in Tokyo, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of four patents to his name, Itahana has innovated compounds that target critical health issues, showcasing his dedication to advancing medical science.

Latest Patents

Among Itahana's latest inventions is the acylguanidine derivative or salt thereof. This compound aims to prevent and treat diseases associated with 5-HT receptors, particularly irritable bowel syndrome (IBS) and migraines. Itahana's research demonstrated that a tricyclic acylguanidine derivative exhibits strong antagonism to both 5-HT receptors, leading to superior pharmacological action when used compared to selective antagonists.

Another significant invention is the aminomethyl-substituted thiazolobenzimidazole compound. This innovative derivative shows promise due to its action on metabotropic glutamate receptors and excellent oral bioavailability, marking it as a vital candidate for medicinal applications.

Career Highlights

Hirotsune Itahana's career spans notable roles in prestigious pharmaceutical corporations, including Yamanouchi Pharmaceutical Company Ltd. and Astellas Pharma GmbH. His tenure at these companies has undoubtedly enriched his expertise and facilitated his groundbreaking research and inventions.

Collaborations

Throughout his career, Itahana has collaborated with skilled colleagues such as Satoshi Hayashibe and Masamichi Okada. These partnerships have contributed to the refinement and success of his innovative drug development projects.

Conclusion

Hirotsune Itahana stands out as a leading inventor in the field of pharmaceutical chemistry. His dedication to developing compounds that address significant medical issues not only reflects his innovative spirit but also emphasizes the crucial role of collaboration in scientific advancement. As he continues to explore new frontiers in drug discovery, the impact of his work will undoubtedly resonate in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…